This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Splinter, M. Y. Articles by Allen, L. V. Search for Related Content PubMed PubMed Citation Articles by Splinter, M. Y. Articles by Allen, L. V., JR. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PHENYTOIN SODIUM Social Bookmarking                         What's this?

Effect of pH on the Equilibrium Dialysis of Phenytoin Suspension with and without Enteral Feeding Formula

Oklahoma Memorial Hospital, Oklahoma City, Oklahoma

Charles F. Seifert, PHARM.D.

Section of the Pharmacy Practice, University of Oklahoma Health Sciences Center

J. Christopher Bradberry, PHARM.D.

Section of the Pharmacy Practice, University of Oklahoma Health Sciences Center

Yu-Hsing Tu, PH.D.

Section of Pharmaceutics, College of Pharmacy, University of Oklahoma Health Sciences Center

Loyd V. Allen, JR., PH.D.

Section of Pharmaceutics, College of Pharmacy, University of Oklahoma Health Sciences Center

Significant decreases have been reported in phenytoin absorption when the suspension is combined with continuous enteral feedings. Several theories for this interaction have been proposed including binding of phenytoin to the protein constituents of the enteral formula, phenytoin binding to the calcium in the enteral formula, and inadequate dissolution of the suspension when delivered with the enteral formula due to the high pKa of phenytoin and the acidic nature of the enteral formula. We therefore evaluated the effects of pH levels 2.0, 3.5, 6.0, and 8.0 on the interaction of phenytoin suspension with enteral formula (Osmolite) with equilibrium dialysis using a Spectra/Por 1 (MWCO 6000-8000) molecularporous dialysis membrane. Phenytoin concentrations in the dialysis membrane (internal phase) mimicked the expected stomach concentrations of a 100-mg dose administered in an adult stomach containing 200 ml of gastric fluid. External phase buffers were sampled at 0.5, 1.0, 2.0, 4.0, 8.0, 12.0, and 24.0 hr after the start of the dialysis. The phenytoin concentrations in the external phase were compared between buffer alone or buffer combined with enteral formula at the same pH and time intervals. With pH 2.0 and 3.5 the enteral formula formed an aggregate with suspension whereas no aggregate was formed with pH 6.0 and 8.0. The phenytoin concentrations with pH 2.0 were 26% to 44% lower and with pH 3.5 were 11.5 to 27% lower when phenytoin suspension was combined with enteral solution. However, at 24 hr there was no difference between the two conditions with both pH 2.0 and 3.5. With pH 6.0 there was a significant difference at 24 hr and with pH 8.0 significant differences were reached only at 0.5, 1.0 and 2.0 hr. These results show that the phenytoin suspension/enteral formula interaction is pH dependent. There appears to be a physical entrapment of the large suspension particles when the protein in the enteral solution denatures at lower pH's. These results may in part explain the decreased erratic absorption when phenytoin suspension is combined with enteral feedings. (Journal of Parenteral and Enteral Nutrition 14:275-278, 1990)

Journal of Parenteral and Enteral Nutrition, Vol. 14, No. 3, 275-278 (1990)
DOI: 10.1177/0148607190014003275


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Justice Phenytoin Monitoring in the Intensive Care Unit Journal of Pharmacy Practice, February 1, 1995; 8(1): 29 - 38. [Abstract] [PDF]